Original-Research: Nabaltec AG (von NuWays AG): BUY
Source: EQS
Classification of
FY24 marked by strong op. CF; soft start into FY25 2024 figures inline with prelims. To recap: FY24 sales grew by 1.7% yoy to € 203.6m, largely driven by higher sales volumes of fine hydroxides and viscosity optimized hydroxides (sales +100% yoy to € 10.2m), which compensated for weaker demand for boehmite (-25% yoy to only € 12.5m due to lacklustre EV demand across At 10.8%, the EBIT margin increased by 1.7pp yoy; € 22.3m absolute EBIT. Thanks to the good operational performance coupled with working capital improvements (wc/sales -3.4pp to 17.8%), the operating cash flow stood at € 35.2m, sufficient to cover the company’s growth investments (€ 32m capex). Soft start into the year. Cautious FY25 guidance. Due to the expected gradual improvements outlined above, management's expectations of 3-5% FY25 sales growth (eNuW: 5.7%) and an EBIT margin of 7-9% (eNuW: 9.7%) look conservative. Potential tailwinds from Germany’s € 1tn spending bazooka. On Valuation remains low. You can download the research here: http://www.more-ir.de/d/32486.pdf For additional information visit our website: https://www.nuways-ag.com/research-feed Contact for questions: Web: www.nuways-ag.com Email: research@nuways-ag.com LinkedIn: https://www.linkedin.com/company/nuwaysag Adresse: Mittelweg 16-17, 20148 ++++++++++ Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse. ++++++++++
The EQS Distribution Services include Regulatory Announcements, |
2131580 07.05.2025 CET/CEST